These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12668610)

  • 1. Alzheimer-associated C allele of the promoter polymorphism -22C>T causes a critical neuron-specific decrease of presenilin 1 expression.
    Theuns J; Remacle J; Killick R; Corsmit E; Vennekens K; Huylebroeck D; Cruts M; Van Broeckhoven C
    Hum Mol Genet; 2003 Apr; 12(8):869-77. PubMed ID: 12668610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The -22c/t polymorphism in presenilin 1 gene is not connected with late-onset and early-onset familial Alzheimer's disease in Poland.
    Zekanowski C; Religa D; Safranow K; Maruszak A; Dziedziejko V; Styczyńska M; Gacia M; Golan M; Pepłońska B; Chlubek D; Kuźnicki J; Barcikowska M
    J Neural Transm (Vienna); 2005 Jun; 112(6):839-45. PubMed ID: 15480851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression.
    Theuns J; Del-Favero J; Dermaut B; van Duijn CM; Backhovens H; Van den Broeck MV; Serneels S; Corsmit E; Van Broeckhoven CV; Cruts M
    Hum Mol Genet; 2000 Feb; 9(3):325-31. PubMed ID: 10655540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic association of the presenilin-1 regulatory region with early-onset Alzheimer's disease in a population-based sample.
    van Duijn CM; Cruts M; Theuns J; Van Gassen G; Backhovens H; van den Broeck M; Wehnert A; Serneels S; Hofman A; Van Broeckhoven C
    Eur J Hum Genet; 1999; 7(7):801-6. PubMed ID: 10573013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable expression of presenilin 1 is not a major determinant of risk for late-onset Alzheimer's disease.
    Dermaut B; Roks G; Theuns J; Rademakers R; Houwing-Duistermaat JJ; Serneels S; Hofman A; Breteler MM; Cruts M; Van Broeckhoven C; van Duijn CM
    J Neurol; 2001 Nov; 248(11):935-9. PubMed ID: 11757955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The -48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased Abeta load in brain.
    Lambert JC; Mann DM; Harris JM; Chartier-Harlin MC; Cumming A; Coates J; Lemmon H; StClair D; Iwatsubo T; Lendon C
    J Med Genet; 2001 Jun; 38(6):353-5. PubMed ID: 11389157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory region variability in the human presenilin-2 (PSEN2) gene: potential contribution to the gene activity and risk for AD.
    Riazanskaia N; Lukiw WJ; Grigorenko A; Korovaitseva G; Dvoryanchikov G; Moliaka Y; Nicolaou M; Farrer L; Bazan NG; Rogaev E
    Mol Psychiatry; 2002; 7(8):891-8. PubMed ID: 12232783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DGGE method for the mutational analysis of the coding and proximal promoter regions of the Alzheimer's disease presenilin-1 gene: two novel mutations.
    Aldudo J; Bullido MJ; Valdivieso F
    Hum Mutat; 1999; 14(5):433-9. PubMed ID: 10533070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association of the -48CT polymorphism of the presenilin 1 gene with Alzheimer disease in a late-onset sporadic population.
    Araria-Goumidi L; Huguet JB; Lambert JC; Frigard B; Cottel D; Amouyel P; Chartier-Harlin MC
    J Neural Transm (Vienna); 2002 Jul; 109(7-8):1023-7. PubMed ID: 12111439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association or linkage between an intronic polymorphism of presenilin-1 and sporadic or late-onset familial Alzheimer disease.
    Scott WK; Yamaoka LH; Locke PA; Rosi BL; Gaskell PC; Saunders AM; Conneally PM; Small GW; Farrer LA; Growdon JH; Roses AD; Pericak-Vance MA; Haines JL
    Genet Epidemiol; 1997; 14(3):307-15. PubMed ID: 9181359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The -980C/G polymorphism in APH-1A promoter confers risk of Alzheimer's disease.
    Qin W; Jia L; Zhou A; Zuo X; Cheng Z; Wang F; Shi F; Jia J
    Aging Cell; 2011 Aug; 10(4):711-9. PubMed ID: 21443683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presenilin 1 polymorphism associated with Alzheimer's disease in apolipoprotein E4 carriers.
    Martínez-García A; Aldudo J; Recuero M; Sastre I; Vilella-Cuadrada E; Rosich-Estragó M; Frank A; Valdivieso F; Bullido MJ
    Dement Geriatr Cogn Disord; 2008; 26(5):440-4. PubMed ID: 18957849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased Abeta42 secretion.
    De Jonghe C; Cruts M; Rogaeva EA; Tysoe C; Singleton A; Vanderstichele H; Meschino W; Dermaut B; Vanderhoeven I; Backhovens H; Vanmechelen E; Morris CM; Hardy J; Rubinsztein DC; St George-Hyslop PH; Van Broeckhoven C
    Hum Mol Genet; 1999 Aug; 8(8):1529-40. PubMed ID: 10401002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic study of Sardinian patients with Alzheimer's disease.
    Piscopo P; Manfredi A; Malvezzi-Campeggi L; Crestini A; Spadoni O; Cherchi R; Deiana E; Piras MR; Confaloni A
    Neurosci Lett; 2006 May; 398(1-2):124-8. PubMed ID: 16423463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral leukocyte expression of the potential biomarker proteins Bdnf, Sirt1, and Psen1 is not regulated by promoter methylation in Alzheimer's disease patients.
    Carboni L; Lattanzio F; Candeletti S; Porcellini E; Raschi E; Licastro F; Romualdi P
    Neurosci Lett; 2015 Sep; 605():44-8. PubMed ID: 26275347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
    Cui T; Zhou X; Jin W; Zheng F; Cao X
    Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of presenilin 1 in the genetics of Alzheimer's disease.
    Clark RF; Hutton M; Talbot C; Wragg M; Lendon C; Busfield F; Han SW; Perez-Tur J; Adams M; Fuldner R; Roberts G; Karran E; Hardy J; Goate A
    Cold Spring Harb Symp Quant Biol; 1996; 61():551-8. PubMed ID: 9246481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presenilin E318G variant and Alzheimer's disease risk: the Cache County study.
    Hippen AA; Ebbert MT; Norton MC; Tschanz JT; Munger RG; Corcoran CD; Kauwe JS
    BMC Genomics; 2016 Jun; 17 Suppl 3(Suppl 3):438. PubMed ID: 27357204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that Abeta42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype.
    De Jonghe C; Cras P; Vanderstichele H; Cruts M; Vanderhoeven I; Smouts I; Vanmechelen E; Martin JJ; Hendriks L; Van Broeckhoven C
    Neurobiol Dis; 1999 Aug; 6(4):280-7. PubMed ID: 10448055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between presenilin-1 -48C/T polymorphism and Down's syndrome.
    Lucarelli P; Piciullo A; Palmarino M; Verdecchia M; Saccucci P; Arpino C; Curatolo P
    Neurosci Lett; 2004 Aug; 367(1):88-91. PubMed ID: 15308304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.